Thymoquinone inhibits proliferation and invasion of human nonsmall-cell lung cancer cells via ERK pathway

Inhibition of Raf-MEK-ERK and Hypoxia pathways by Phyllanthus prevents metastasis in human lung (A549) cancer cell line

(2013) Sau Har Lee et al.   BMC Complementary and Alternative Medicine

Carboxypeptidase E promotes cancer cell survival, but inhibits migration and invasion

(2013) Saravana R.K. Murthy et al.   CANCER LETTERS

Silencing Met receptor tyrosine kinase signaling decreased oral tumor growth and increased survival of nude mice

(2013) X. Tao et al.   ORAL ONCOLOGY

CK2 Inhibitor CX-4945 Blocks TGF-β1-Induced Epithelial-to-Mesenchymal Transition in A549 Human Lung Adenocarcinoma Cells

(2013) Jiyeon Kim et al.   PLoS One

Kaempferol Reduces Matrix Metalloproteinase-2 Expression by Down-Regulating ERK1/2 and the Activator Protein-1 Signaling Pathways in Oral Cancer Cells

(2013) Chiao-Wen Lin et al.   PLoS One

Matrix Metalloprotease 2-Responsive Multifunctional Liposomal Nanocarrier for Enhanced Tumor Targeting

(2012) Lin Zhu et al.   ACS Nano

Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growthin vivo

(2012) Samir Attoub et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

MLK4β functions as a negative regulator of MAPK signaling and cell invasion

(2012) W F Abi Saab et al.   Oncogenesis

Thymoquinone: Potential cure for inflammatory disorders and cancer

(2011) Chern Chiuh Woo et al.   BIOCHEMICAL PHARMACOLOGY

Cancer Invasion and the Microenvironment: Plasticity and Reciprocity

(2011) Peter Friedl et al.   CELL

Matrix metalloproteinases in tumorigenesis: an evolving paradigm

(2011) Hui Hua et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Thymoquinone inhibits matrix metalloproteinase expression in rabbit chondrocytes and cartilage in experimental osteoarthritis

(2011) Wei-Ping Chen et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Thymoquinone reduces migration and invasion of human glioblastoma cells associated with FAK, MMP-2 and MMP-9 down-regulation

(2011) Kaouther Kolli-Bouhafs et al.   INVESTIGATIONAL NEW DRUGS

Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathway

(2010) Feng Li et al.   BRITISH JOURNAL OF PHARMACOLOGY

Nicotinamide N -methyltransferase induces cellular invasion through activating matrix metalloproteinase-2 expression in clear cell renal cell carcinoma cells

(2010) Sai-Wen Tang et al.   CARCINOGENESIS

Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo

(2010) Syed H Jafri et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells

(2010) El-Shaimaa A. Arafa et al.   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS

Structure-Activity Studies on Therapeutic Potential of Thymoquinone Analogs in Pancreatic Cancer

(2010) Sanjeev Banerjee et al.   PHARMACEUTICAL RESEARCH

Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases

(2010) E. S. Olson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation

(2010) Schammim R. Amith et al.   Jove-Journal of Visualized Experiments

Cancer screening in the United States, 2009: A review of current American Cancer Society guidelines and issues in cancer screening

(2009) R. A. Smith et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways

(2008) T. Yi et al.   MOLECULAR CANCER THERAPEUTICS